
The ESMO-Magnitude of Clinical Benefit Scale for Hematological Malignancies
Prof Dr Michel Delforge, UZ Leuven, was one of the experts contributing to the first version of the ESMO-Magnitude of Clinical Benefit Scale for hematological malignancies (ESMO-MCBS:H). In this video,